Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.68
Delayed Data
As of Dec 08
 -0.075 / -1.11%
Today’s Change
3.30
Today|||52-Week Range
7.05
+22.48%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close6.75
Today’s open6.85
Day’s range6.60 - 6.85
Volume48,303
Average volume (3 months)147,860
Market cap$191.5M
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+45.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp+0.67+10.72%
NVLNNovelion Therapeutic...+0.14+4.00%
CDTXCidara Therapeutics ...-0.25-3.16%
NATRNatures Sunshine Pro...+0.05+0.41%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateApril 3, 2018
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent J. Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts